Carregant...
Miniatura

Tipus de document

Article

Data de publicació

Llicència de publicació

cc by-nc (c) García Mulero, Sandra et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174051

Lung metastases share common immune features regardless of primary tumor origin

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: Only certain disseminated cells are able to grow in secondary organs to create a metastatic tumor. Under the hypothesis that the immune microenvironment of the host tissue may play an important role in this process, we have categorized metastatic samples based on their immune features. Methods: Gene expression data of metastatic samples (n=374) from four secondary sites (brain, bone, liver and lung) were used to characterize samples based on their immune and stromal infiltration using gene signatures and cell quantification tools. A clustering analysis was done that separated metastatic samples into three different immune categories: high, medium and low. Results: Significant differences were found between the immune profiles of samples metastasizing in distinct organs. Metastases in lung showed a higher immunogenic score than metastases in brain, liver or bone, regardless of their primary site of origin. Also, they preferentially clustered in the high immune group. Samples in this cluster exhibited a clear inflammatory phenotype, higher levels of immune infiltrate, overexpression of programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) pathways and upregulation of genes predicting clinical response to programmed cell death protein 1 (PD-1) blockade (T-cell inflammatory signature). A decision tree algorithm was used to select CD74 as a biomarker that identify samples belonging to this high-immune subtype of metastases, having specificity of 0.96 and sensitivity of 1. Conclusions: We have found a group of lung-enriched metastases showing an inflammatory phenotype susceptible to be treated with immunotherapy.

Citació

Citació

GARCÍA MULERO, Sandra, ALONSO AGUADO, Maria henar, PARDO, Julián, SANTOS, Cristina, SANJUAN, Xavier, SALAZAR SOLER, Ramón, MORENO AGUADO, Víctor, PIULATS, Josep m., SANZ PAMPLONA, Rebeca. Lung metastases share common immune features regardless of primary tumor origin. _Journal for ImmunoTherapy of Cancer_. 2020. Vol. 8, núm. 1, pàgs. e000491. [consulta: 24 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/174051]

Exportar metadades

JSON - METS

Compartir registre